Landmark Clinical Trial Results in First FDA-Approved Treatment for Rare Form of Obesity Caused by Brain Injury
Children and adults living with a rare condition that causes rapid, uncontrollable weight gain now have a new treatment option following the U.S. Food and Drug Administration's approval of…
Read the full articleYou might also wanna read
Targeted Therapy Reverses Weight Gain From Rare Cause of Obesity
(MedPage Today) -- Treatment with setmelanotide (Imcivree), a melanocortin-4 receptor (MC4R) agonist, led to significant reductions in body
Dutch researchers report breakthrough in treatment of obesity caused by brain tumor
Researchers have reported a breakthrough in the treatment of people struggling with obesity due to hormonal imbalances caused by a brain tum
The unregulated peptide boom: Americans risk unknown side effects for quick-fix weight loss and anti-aging drugs
Across the US, thousands of people are injecting themselves with unregulated peptides in pursuit of weight loss, muscle growth and younger-l
theguardian.com·24d ago
FDA Clears NIH-Supported Gene Therapy MMA-101 for First Human Trial in Rare Metabolic Disorder
MMA-101, an NIH-supported gene therapy for a rare metabolic disorder, has received FDA clearance to begin clinical testing.
ncats.nih.gov·11d agoAn Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
Conditions : Obesity; Methamphetamine Use Disorder; Cocaine Use Disorder; Stimulant Use Disorders Interventions : Drug: Tirzepatide Sponsors
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Conditions : Overweight or Obesity Interventions : Drug: Olatorepatide; Drug: Placebo Sponsors : Regeneron Pharmaceuticals Not yet recruitin
Comments
Sign in to join the conversation.
No comments yet. Be the first.